Search Form
First, enter a politician or zip code
Now, choose a category
 

Greg Walden's Public Statements

Office: U.S. House (OR) - District 2, Republican
Date Title
March 22, 2017 Hearing of the Environment Subcommitee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on H.R. 806, Ozone Standards Implementation Act of 2017
March 21, 2017 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Fentanyl: The Next Wave of the Opioid Crisis
March 21, 2017 Hearing of the Communications and Technology Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Broadband: Deploying America's 21st Century Infrastructure
March 20, 2017 Letter to the Hon. Rick Perry, Secretary of Energy - Provide Insight on Nuclear Waste Management Policy
March 20, 2017 House Republicans Announce Updates to Strengthen American Health Care Act
March 16, 2017 Hearing of the Environment Subcommitee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Reinvestment and Rehabilitation of Our Nation's Safe Drinking Water Delivery Systems
March 15, 2017 Letter to Dr. Stephen Ostroff, Acting Commissioner of the Food and Drug Administration - Provide Documents Related to Heparin Contamination Crisis
March 13, 2017 Walden and Burgess Comment on Seema Verma's Confirmation as CMS Administrator
March 13, 2017 Walden Statement on CBO Score of American Health Care Act
March 9, 2017 Energy and Commerce Committee Advances Legislation to Repeal and Replace Obamacare
March 7, 2017 Walden on Exxon's Commitment to the Gulf Coast
March 7, 2017 The Wall Street Journal - The Health Bill You've Waited For
March 6, 2017 Energy and Commerce Republicans Release Legislation to Repeal and Replace Obamacare
March 6, 2017 E&C Releases Compendium on Obamacare Oversight
March 2, 2017 Letter to the hon. Donald J. Trump - Swiftly Fill FERC Vacancies
March 2, 2017 Committee Leaders on Secretary Perry's Confirmation
March 2, 2017 Walden Statement on Repealing and Replacing Obamacare
Feb. 28, 2017 Letter to Dr. Schuchat, Acting Director for the Centers for Disease Control nad Prevention - Provide
Feb. 28, 2017 Walden Statement on President Trump's Health Care Reform Plan
Feb. 28, 2017 #SubOversight Examines International Anti-Doping System With All-Star Panel
Feb. 27, 2017 Walden Statement on Confirmation of Wilbur Ross as Commerce Secretary
Feb. 23, 2017 Letter to Mr. Kemp Chester, Acting Director of the the Office of National Dug Control Policy - Provide Assistance in Questioning all Federal Agencies on Plans to Address Fentanyl
Feb. 21, 2017 Letter to Ms. Catherine McCab, Acting Administrator of the U.S. Environmental Protection Agency; Mr. Kevin Minoli, Acting General Counsel of the U.S. Environmental Protection Agency; and Mr. Donald Benton, White House Liaison to the U.S. Environmental Protection Agency - Please Grant 120-Day Extension to EPA's PRoposed Rule
Feb. 21, 2017 Bipartisan Group of Senate and House Committee Leaders: "Vaccines Save Lives"
Feb. 21, 2017 Letter to Congressional Colleagues - Vaccines Save Lives
Feb. 17, 2017 Walden & Shimkus on Pruitt's Confirmation to Head EPA
Feb. 16, 2017 Walden Introduces Bill to Protect Patients with Pre-Existing Conditions
Feb. 15, 2017 Walden, Burgess Praise Move to Deliver Immediate Obamacare Relief
Feb. 15, 2017 Bipartisan Committee Leaders Comment on Incentive Auction's Conclusion
Feb. 14, 2017 Walden Comments on Humana's Departure from Obamacare Markets
Feb. 7, 2017 New Report Highlights Need for Improved Medicaid Oversight
Feb. 7, 2017 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Markup on H.R. 829 and H.R. 181
Feb. 7, 2017 New Report Highlights Need for Improved Medicaid Oversight
Feb. 3, 2017 Walden Comments on 2017 Obamacare Enrollment
Feb. 3, 2017 Walden & Blackburn Applaud Pai's Work to Rescind a Number of FCC Orders
Feb. 2, 2017 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Patient Relief from Collapsing Health Exchanges
Feb. 2, 2017 Walden & Blackburn Applaud Chairman Pai's Move to Increase Transparency at FCC
Feb. 2, 2017 Hearing of the Communications and Technology Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Reauthorization of the National Telecommunications and Information Administration
Feb. 1, 2017 Hearing of the Energy Subcommittee of the House Energy and Commerce Committee - Opening Statement by Rep. Walden, Hearing on the Electricity Sector's Efforts to Respond to Cybersecurity Threats
Jan. 31, 2017 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing n Medicaid Oversight: Existing Problems and Ways to Strengthen the Program
Jan. 25, 2017 Letter to the Hon. Ajit Pai, Federal Communications Commission Chairman - Close the docket on Set-Top Box Proceeding
Jan. 24, 2017 Walden, Upton, and Shimkus Applaud President Trump's Executive Actions on Pipelines
Jan. 23, 2017 Walden and Blackburn Statement on Pai's Appointment to Head FCC
Jan. 23, 2017 Walden Statement on Rep. Pompeo Confirmation as CIA Director
Jan. 23, 2017 Burgess Comments on President Trump's Executive Action Reinstating Mexico City Policy
Jan. 20, 2017 Greg Walden Statement on the Owyhee Canyonlands
Jan. 20, 2017 Walden Comments on President Trump's Executive Action Addressing Burdens of Obamacare
Jan. 19, 2017 Walden, Pallone Applaud FDA's Establishment of Oncology Center of Excellence
Jan. 19, 2017 NEW REPORT: Nonpartisan Government Watchdog Cautions CMS to Halt Phase-In of Encounter Data Program to Ensure Proper Medicare Advantage Payments
Jan. 17, 2017 Nonpartisan Watchdog: FDA Still Lacks Inspection Data on Almost 1,000 Foreign Drug Firms Shipping to U.S.
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top